Open an account

CardioGenics Holdings

CGNH · OTC

$0.0001+$0.0001 (+0.00%)TodayMarket closed ·
No price history for this range.

About CGNH

CardioGenics Holdings, Inc. is a biotechnology company, which engages in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. The company is headquartered in Boca Raton, Florida. The company went IPO on 2004-06-09. The firm has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees
4
Headquarters
Boca Raton, Florida
Listed
Jun 9, 2004
Sector
Health Care
Industry
Biotechnology
Website
cardiogenics.com

CGNH key statistics

Market cap
9.61K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
29.88K
Volume
4.00K
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.0001
52 Week low
$0.00

CardioGenics Holdings (CGNH) at a glance

As of Oct 6, 2026, CardioGenics Holdings (CGNH) shares are priced at $0.0001, giving the company a market cap of 9.61K and a price-to-earnings ratio of 0.00.

Volume so far is 4.00K shares, below the average of 29.88K shares a day.

Over the past year CardioGenics Holdings has ranged from $0.00 to $0.0001, and now sits 100% of the way up that range.

CardioGenics Holdings met or beat analyst EPS estimates in 3 of the last 3 quarters. In Q2 FY11 it reported -$0.01 per share against an estimate of -$0.0102.

CGNH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 3 quarters, by 34.6% on average.

  1. Q4 FY10: reported -$0.01 per share against an estimate of -$0.0102
  2. Q1 FY11: reported $0.00 per share against an estimate of -$0.0102
  3. Q2 FY11: reported -$0.01 per share against an estimate of -$0.0102

Similar companies

Companies in the same industry as CardioGenics Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.